Statistics at a Glance
At a Glance
Estimated New Cases in 2018 8,500
% of All New Cancer Cases 0.5%
Estimated Deaths in 2018 1,050
% of All Cancer Deaths 0.2%
|Year||New Cases - SEER 9||New Cases - SEER 13||Deaths - U.S.||Percent Surviving 5 Years - SEER 9|
Number of New Cases and Deaths per 100,000: The number of new cases of Hodgkin lymphoma was 2.5 per 100,000 men and women per year. The number of deaths was 0.3 per 100,000 men and women per year. These rates are age-adjusted and based on 2011-2015 cases and deaths.
Lifetime Risk of Developing Cancer: Approximately 0.2 percent of men and women will be diagnosed with Hodgkin lymphoma at some point during their lifetime, based on 2013-2015 data.
Prevalence of This Cancer: In 2015, there were an estimated 208,805 people living with Hodgkin lymphoma in the United States.
How Many People Survive 5 Years Or More after Being Diagnosed with Hodgkin Lymphoma?
Relative survival statistics compare the survival of patients diagnosed with cancer with the survival of people in the general population who are the same age, race, and sex and who have not been diagnosed with cancer. Because survival statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. No two patients are entirely alike, and treatment and responses to treatment can vary greatly.
Based on data from SEER 18 2008-2014. Gray figures represent those who have died from Hodgkin lymphoma. Green figures represent those who have survived 5 years or more.
Survival by Stage
Cancer stage at diagnosis, which refers to extent of a cancer in the body, determines treatment options and has a strong influence on the length of survival. In general, if the cancer is found only in the part of the body where it started it is localized (sometimes referred to as stage 1). If it has spread to a different part of the body, the stage is regional or distant. For Hodgkin lymphoma, 39.6% are diagnosed at the local stage. The 5-year survival for localized Hodgkin lymphoma is 93.4%.
|Stage||Percent of Cases||5-Year Relative Survival|
Only in Originating Layer of Cells
Confined to Primary Site
Spread to Regional Lymph Nodes
Cancer has Metastasized
SEER 18 2008-2014, All Races, Both Sexes by Ann Arbor Stage
Number of New Cases and Deaths
How Common Is This Cancer?
Compared to other cancers, Hodgkin lymphoma is rare.
|Rank||Common Types of Cancer||Estimated New
|1.||Breast Cancer (Female)||266,120||40,920|
|2.||Lung and Bronchus Cancer||234,030||154,050|
|5.||Melanoma of the Skin||91,270||9,320|
|8.||Kidney and Renal Pelvis Cancer||65,340||14,970|
Hodgkin lymphoma represents 0.5% of all new cancer cases in the U.S.
In 2018, it is estimated that there will be 8,500 new cases of Hodgkin lymphoma and an estimated 1,050 people will die of this disease.
Who Gets This Cancer?
Hodgkin lymphoma is more common among young adults and among men than women. It can occur in both adults and children; however, treatment for adults may be different than treatment for children. Hodgkin lymphoma may also occur in patients who have acquired immunodeficiency syndrome (AIDS); these patients require special treatment. The number of new cases of Hodgkin lymphoma was 2.5 per 100,000 men and women per year based on 2011-2015 cases.
|American Indian/Alaska Native||1.5|
|American Indian/Alaska Native||1.3|
SEER 18 2011-2015, Age-Adjusted
|Age Range||Percent of New Cases|
Hodgkin lymphoma is most frequently diagnosed among people aged 20-34.
SEER 18 2011-2015, All Races, Both Sexes
Who Dies From This Cancer?
The number of deaths was 0.3 per 100,000 men and women per year based on 2011-2015 deaths.
|American Indian/Alaska Native||Not Shown, <16 cases|
|American Indian/Alaska Native||Not Shown, <16 cases|
U.S. 2011-2015, Age-Adjusted
|Age Range||Percent of Deaths|
The percent of Hodgkin lymphoma deaths is highest among people aged 75-84.
U.S. 2011-2015, All Races, Both Sexes
Trends in Rates
Changes Over Time
Keeping track of the number of new cases, deaths, and survival over time (trends) can help scientists understand whether progress is being made and where additional research is needed to address challenges, such as improving screening or finding better treatments.
Using statistical models for analysis, rates for new Hodgkin lymphoma cases have been falling on average 1.8% each year over the last 10 years. Death rates have been falling on average 2.8% each year over 2006-2015. 5-year survival trends are shown below.
New cases come from SEER 9 Incidence. Deaths come from U.S. Mortality. 1975-2015, All Races, Both Sexes. Rates are Age-Adjusted.
SEER 9 5-Year Relative Survival Percent from 1975-2010, All Races, Both Sexes.View Data Table
More About This Cancer
Figure: Anatomy of the lymph system, showing the lymph vessels and lymph organs including lymph nodes, tonsils, thymus, spleen, and bone marrow. Lymph (clear fluid) and lymphocytes travel through the lymph vessels and into the lymph nodes where the lymphocytes destroy harmful substances. The lymph enters the blood through a large vein near the heart.
Hodgkin lymphoma is a cancer of the immune system that is marked by the presence of a type of cell called the Reed-Sternberg cell. The two major types of Hodgkin lymphoma are classical Hodgkin lymphoma and nodular lymphocyte-predominant Hodgkin lymphoma. Symptoms include the painless enlargement of lymph nodes, spleen, or other immune tissue. Other symptoms include fever, weight loss, fatigue, or night sweats. Also called Hodgkin disease.
Here are some resources for learning more about Hodgkin lymphoma.
- More about risk factors for Hodgkin lymphoma cancer
- More about symptoms and diagnosis of Hodgkin lymphoma cancer
- More about treatment options for Hodgkin lymphoma cancer
- More about clinical trials
- More about cancer prevention
All statistics in this report are based on statistics from SEER and the Centers for Disease Control and Prevention's National Center for Health Statistics. Most can be found within:
Noone AM, Howlader N, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2015, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2015/, based on November 2017 SEER data submission, posted to the SEER web site, April 2018.
All material in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.
SEER Cancer Stat Facts: Hodgkin Lymphoma. National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/statfacts/html/hodg.html
These stat facts focus on population statistics that are based on the U.S. population. Because these statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. To see tailored statistics, browse the SEER Cancer Statistics Review. To see statistics for a specific state, go to the State Cancer Profiles.
The statistics presented in these stat facts are based on the most recent data available, most of which can be found in the SEER Cancer Statistics Review. In some cases, different year spans may be used. Estimates for the current year are based on past data.
Cancer is a complex topic. There is a wide range of information available. These stat facts do not address causes, symptoms, diagnosis, treatment, follow-up care, or decision making, although links are provided to information in many of these areas.